NEW BETA-2-PROLONGED EFFECT AGONISTS AND ITS USE AS MEDICATIONS.

摘要

15) Pharmaceutical formulation for inhalation application, characterized by a content of a compound of formula 1 according to one of claims 1 to 11. 16) Pharmaceutical formulation for inhalation application according to claim 15, characterized in that it is selected from the group consisting of powders for inhalation, dosing aerosols with propellant gas content and solutions for inhalation without propellant gas. 59 27 Case